InsidersTradesSigma
Track the Dr. Lal Path Labs Ltd. share price and the full insider trade history of the company, a listed equity based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Dr. Lal Path Labs Ltd. has published 877 public disclosures. Market capitalisation: €326.1bn. The latest transaction was disclosed on 1 May 2026 (Purchase). Among the most active insiders: Dr. Lal PathLabs Employees Welfare Trust. All data is free.
877
Insider Decl.
n/a
Thresholds
€12m
355 ops.
Buy Volume
€87m
521 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Dr. Lal Path Labs Ltd. Buy (bullish), based on 26 analysts. Average price target: ₹1,927.85.
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,916 of 29,062 companies
59.5
score / 100
Value32
Quality87
FCF yld1.4%
Earn yld1.6%
EV/EBITDA38.0x
ROE21%
Gross mgn81%
Net mgn18%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 May 2026
Declarations877 total
82,750 shares@ ₹1,141.200.0003% mcap100.0% of flowEquity SharesSEBI:8b012cc53062923f0f2687dce98eef605f9e9f7b
1,000 shares@ ₹1,302.700.0000% mcap0.4% of flowEquity SharesSEBI:e04ed63654c585f52596714c1ecc0e354dfb9599
2,024 shares@ ₹761.85570.1% of flowEquity SharesSEBI:09943fcf986cfecd303497d8702237d004d71541
1,500 shares@ ₹1,026.25075.7% of flowEquity SharesSEBI:fbbdfb416836614c2045b4fde14279f6c6b90cf2
1,876 shares@ ₹357.21320.1% of flowEquity SharesSEBI:3ca758f4a95e8e80365714821d8905de69f0b4d2
2,470 shares@ ₹1,444.9081.3% of flowEquity SharesSEBI:0d764ee1ff035e91e70600a162c85f1244f3235c
4,000 shares@ ₹155.650.2% of flowEquity SharesSEBI:bb6e9970ba4bc5c9e61412678dbbdffc6f09e630
2,500 shares@ ₹1,462.801.2% of flowEquity SharesSEBI:4f736f5a04ffdc28c700aab6002e93065456fef2
2,500 shares@ ₹1,014.00611.5% of flowEquity SharesSEBI:bc09e0ecd4ebc8d1f6043ffb116af6837e5e30ae
424 shares@ ₹5.000.0% of flowEquity SharesSEBI:e40c05b41d2a005c1c9a69a431a75a750b6dd907
250 shares@ ₹10.000.0% of flowEquity SharesSEBI:41923ec0102249f604a2a371b38e826f98f67dc8
1,750 shares@ ₹1,453.009.5% of flowEquity SharesSEBI:af7d6c0111386e0ac314f4271d2e5ad10b4c6d89
4,424 shares@ ₹575.18870.2% of flowEquity SharesSEBI:fe8d3542291268e73082c4d5edbdb0e6518b0f2a
2,500 shares@ ₹10.000.0% of flowEquity SharesSEBI:ae6813ba5062052a6ad289ad8eca4118ad7ce7ff
4,350 shares@ ₹230.69560.1% of flowEquity SharesSEBI:03c18163a15f9074fd5a6990aafca60bc12b3109
450 shares@ ₹10.000.1% of flowEquity SharesSEBI:3923c6bdcf7d84168a978e8a5a587ef9c7aa20a0
750 shares@ ₹10.0011.0% of flowEquity SharesSEBI:8034458aba519b94b4b037c9c9f22d0cb030aaa2
686 shares@ ₹709.72740.0% of flowEquity SharesSEBI:cdea453e786a35f74e4d713d78b28e4d4b8371dc
3,200 shares@ ₹10.000.0% of flowEquity SharesSEBI:ee0faa3b258fd5d5b5093b748dda3e7973f98209
3,200 shares@ ₹10.000.9% of flowEquity SharesSEBI:9998a8c02e4f59f5b27389fa56a33dd7269d79b0
950 shares@ ₹10.0014.4% of flowEquity SharesSEBI:dfd2fea136d8f5c3649a453c14dcffeb9ef53776
1,436 shares@ ₹436.70540.1% of flowEquity SharesSEBI:6a74ab8828f386470d11afc4d084361109327905
5,250 shares@ ₹10.000.1% of flowEquity SharesSEBI:36399c027fb0be145dbad3f2f718af66be196d49
5,750 shares@ ₹10.000.0% of flowEquity SharesSEBI:853c5934e66c33a88f76b8c0b567fe752088081b
3,000 shares@ ₹3,125.76775.5% of flowEquity SharesSEBI:21be029353ef2e4a3ef39fd7f5a390098a678cba
25 of 877 declarations
关于 Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. 是一家印度公司，专门提供医学诊断服务。它提供广泛的实验室检测和健康服务。